Form 8-K - Current report:
SEC Accession No. 0001104659-25-113968
Filing Date
2025-11-19
Accepted
2025-11-19 08:30:34
Documents
12
Period of Report
2025-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2531634d1_8k.htm   iXBRL 8-K 23616
  Complete submission text file 0001104659-25-113968.txt   186372

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gild-20251115.xsd EX-101.SCH 3008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20251115_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20251115_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2531634d1_8k_htm.xml XML 3562
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 251496686
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)